DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal drug ...

The US Food and Drug Administration (FDA) has approved Medtronic's personal therapy manager (myPTM), which works with the company's SynchroMed II intrathecal drug delivery system for patients who ...

Study design: Retrospective single centre study. Objectives: To evaluate a low-dose radioisotope imaging procedure for assessment of implanted intrathecal drug delivery and to compare the radiation ...

March 25, 2008 — A class 1 recall has been announced for Medtronic Neuromodulation's implantable infusion pumps, the US Food and Drug Administration (FDA) announced on March 21. The action was based ...

Medical device maker Medtronic is advising doctors and patients to pay close attention to all malfunction alarms on implantable SynchroMed II drug pumps because of a problem that has caused a handful ...

The Food and Drug Administration (FDA) has approved design changes and a new programming interface for Medtronic's SynchroMed II implantable drug pump, months after federal authorities lifted sales ...

Intrathecal Pumps are an infusion of saline, generally no more than three ounces each, into a sac, either under the breastbone or in the abdomen. Intrathecal Pumps are used for many conditions, ...

(Reuters) - Medtronic Plc has agreed to stop manufacturing and distributing its SynchroMed implantable drug pump, U.S. regulators said on Monday, a step toward resolving allegations that the company ...

Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively "Kessler") conducted the first prospective study to assess whether transcutaneous spinal stimulation (TSS) ...

MINNEAPOLIS--(BUSINESS WIRE)-- As part of its ongoing commitment to keep patients and physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) is issuing an urgent Medical ...